Medical Research
Don't forget to reserve your room for Pathology Visions 2016! The DPA has secured a discounted room rate for attendees of Pathology Visions 2016 at the Manchester Grand Hyatt. The Pathology Visions room block will close today - Friday,...
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crossw...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- Electronic Medical Records
- File format
- General Healthcare News
- Image Analysis
- Informatics
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...
Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report...
Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention. In one of the pieces I mentioned...
Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...
































